JPWO2022269665A1 - - Google Patents

Info

Publication number
JPWO2022269665A1
JPWO2022269665A1 JP2023529196A JP2023529196A JPWO2022269665A1 JP WO2022269665 A1 JPWO2022269665 A1 JP WO2022269665A1 JP 2023529196 A JP2023529196 A JP 2023529196A JP 2023529196 A JP2023529196 A JP 2023529196A JP WO2022269665 A1 JPWO2022269665 A1 JP WO2022269665A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023529196A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022269665A1 publication Critical patent/JPWO2022269665A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023529196A 2021-06-21 2021-06-21 Pending JPWO2022269665A1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/023336 WO2022269665A1 (ja) 2021-06-21 2021-06-21 外用剤

Publications (1)

Publication Number Publication Date
JPWO2022269665A1 true JPWO2022269665A1 (https=) 2022-12-29

Family

ID=84544288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023529196A Pending JPWO2022269665A1 (https=) 2021-06-21 2021-06-21

Country Status (2)

Country Link
JP (1) JPWO2022269665A1 (https=)
WO (1) WO2022269665A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01503061A (ja) * 1987-03-20 1989-10-19 ガルデルマ エスアー 局所的メトロニダゾール製剤
JPH02503004A (ja) * 1988-01-15 1990-09-20 ガルデルマ エスアー 局所メトロニダゾール製剤
JP2011513304A (ja) * 2008-02-27 2011-04-28 アラーガン、インコーポレイテッド 酒さを処置するためのダプソン
JP2016523968A (ja) * 2013-07-08 2016-08-12 ガルデルマ・ソシエテ・アノニム イベルメクチンによる丘疹膿疱性の酒さの治療

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01503061A (ja) * 1987-03-20 1989-10-19 ガルデルマ エスアー 局所的メトロニダゾール製剤
JPH02503004A (ja) * 1988-01-15 1990-09-20 ガルデルマ エスアー 局所メトロニダゾール製剤
JP2011513304A (ja) * 2008-02-27 2011-04-28 アラーガン、インコーポレイテッド 酒さを処置するためのダプソン
JP2016523968A (ja) * 2013-07-08 2016-08-12 ガルデルマ・ソシエテ・アノニム イベルメクチンによる丘疹膿疱性の酒さの治療

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WOLF, JOHN E. ET AL., THERAPEUTICS FOR THE CLINCIAN, vol. Vol.79, p.73-80, JPN6025032033, 2007, ISSN: 0005828818 *

Also Published As

Publication number Publication date
WO2022269665A1 (ja) 2022-12-29

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016200A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260331